Thalidomide prescribers cannot assign survey responsibility to pharmacists.
Young
Donna
D
D000014:Abnormalities, Drug-Induced; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003625:Data Collection; D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D007258:Informed Consent; D007917:Leprostatic Agents / Q000009:adverse effects*; D016365:Liability, Legal; D008297:Male; D010353:Patient Education as Topic; D010593:Pharmaceutical Services; D010595:Pharmacists / Q000941:ethics / Q000331:legislation & jurisprudence*; D010820:Physicians / Q000941:ethics / Q000331:legislation & jurisprudence*; D011247:Pregnancy; D012308:Risk Management; D013792:Thalidomide / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D007917:Leprostatic Agents; D013792:Thalidomide